MEDIA RELEASE

Melbourne – December 2024 – Redenlab, a leader in innovative healthcare solutions, has partnered with the Queensland Institute of Medical Research – Berghofer (QIMR) in Australia to undertake one of the world’s largest studies on the genetics and speech characteristics of Parkinson’s disease.

This groundbreaking collaboration involves up to 14,000 participants contributing critical data to uncover the genetic and speech-based markers of Parkinson’s disease, a progressive neurological disorder that affects millions worldwide.

“We are proud to join forces with QIMR Berghofer on this transformative project,” said Prof Adam Vogel, Chief Science Officer at Redenlab. “Our goal is to properly answer questions on how communication in Parkinson’s disease evolves by integrating cutting edge genetic analysis with detailed speech and language analytics. This approach has the potential to open new pathways for earlier detection, monitoring change and personalised treatment strategies.”

Parkinson’s disease is characterised by motor and speech impairments, often linked to genetic and neurological changes. By combining advanced genomic tools and innovative speech analysis, the study aims to identify specific biomarkers associated with disease onset and progression, ultimately improving patient outcomes.

The collaboration underscores Redenlab’s commitment to advancing the understanding of neurodegenerative diseases through innovative, data driven approaches. The study’s findings are expected to have a significant impact on the development of diagnostic and monitoring tools and therapies for Parkinson’s disease.

For more information, please visit –https://www.qimrberghofer.edu.au/

For media inquiries and interview requests, please contact:

Gloria Macan
Director, Marketing and Communications
Redenlab
Gmacan@redenlab.com

About Redenlab:
Redenlab is a leading techbio company specialising in speech analysis and linguistic
assessment tools. With a mission to enhance decision making in clinical trials and healthcare
research, Redenlab leverages leading knowledge in communication and technology to
measure and analyse speech patterns, providing valuable insights into neurological
conditions. Their innovative solutions are paving the way for improved monitoring and
diagnostics, personalised treatment plans, and transformative advancements in
neuroscience research.